Steve Ditto Articles

Person looking at laptop with bemused expression

Aug 12, 2021 by Steve Ditto

Illumina Delivers a Beat and a Raise in Q2

According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders."

Aug 2, 2021 by Steve Ditto

Is It Too Late to Buy Idexx Laboratories?

This pet healthcare company is giving vets what they need, and its stock has been doing the same for investors.

Jul 31, 2021 by Steve Ditto

Bets on Pets: Is Chewy or Idexx a Better Buy?

Two growth stock to play the exploding pet care market One sells to consumers, the other sells to vets. Which is the better investment?

Jul 28, 2021 by Steve Ditto

Better Buy: Vertex vs. CRISPR

Vertex might be undervalued, CRISPR Therapeutics might be overvalued, but both are looking for a home run.

Healthcare Worker Giving Vaccine to Young Person

Jul 28, 2021 by Steve Ditto

Is Novavax a Buy?

After moving at less than warp speed, can this vaccine company catch up to the global opportunity?

Jul 28, 2021 by Steve Ditto

Is Moderna a Buy?

Moderna is riding high on the COVID-19 wave. Is it too late to get in?

Jul 28, 2021 by Steve Ditto

3 Things About Regeneron That Smart Investors Know

The biotech's COVID-19 antibody cocktail made headlines last year, but there's a bigger story here.

Adult with child receiving breathing treatment

Jul 22, 2021 by Steve Ditto

3 Things About Vertex Pharmaceuticals That Smart Investors Know

Can one multibillion-dollar blockbuster breakthrough lead to another?

Jul 21, 2021 by Steve Ditto

3 Things About CRISPR Therapeutics That Smart Investors Know

The company is on track to be the first to market with a gene-editing therapy for blood disorders.

Jul 13, 2021 by Steve Ditto

Is Illumina a Buy?

Illumina has gained almost 29% this year and could be headed higher.

Jul 13, 2021 by Steve Ditto

3 Things About Fulgent Genetics That Smart Investors Know

Few companies had bigger tailwinds from COVID-19. What comes next could be even bigger.

scientist wearing a white lab coat, gloves, and mask works in a lab setting.

Jul 12, 2021 by Steve Ditto

3 Things About Invitae That Smart Investors Should Know

Could Invitae become the first $1 trillion market cap healthcare company?

Jul 9, 2021 by Steve Ditto

Where Will ARK Genomic Revolution ETF Be in 5 Years?

Cathie Wood's genomics ETF is making big bets on the "Genomic Age."

Jul 9, 2021 by Steve Ditto

Is It Too Late to Buy Intellia Therapeutics?

After skyrocketing 68% last week, will this stock keep running higher?

Jun 22, 2021 by Steve Ditto

Has Illumina Lost Its Shine?

Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track?

A pharmacist helps a mature person with with a script at the pharmacy counter

Jun 15, 2021 by Steve Ditto

Is GoodRx the Prescription for Your Portfolio?

You're probably paying too much for your drugs. Fortunately, there's some help on the way.

scientist peers into a microscope while wearing full personal protective gear, while colleagues work at a counter to her left.

Jun 25, 2021 by Steve Ditto

What Does Life After COVID Look Like for Fulgent Genetics?

Fulgent rode on a wave of COVID revenue. What comes next could be pretty special.

Mature person sits in front of laptop in a kitchen, navigating on the computer while reading the label of a pill bottle in her hand.

Jun 22, 2021 by Steve Ditto

Is Amazon Becoming a Healthcare Company?

Amazon has set its sights on the $4 trillion U.S. healthcare market.

scientist wearing googles and gloves uses tools in laboratory

May 28, 2021 by Steve Ditto

Can Invitae Be the Winner-Take-Most in Genetic Testing?

Just like in poker, in some markets, the winner can take the whole pot. Can Invitae take home all the chips?

surgeon wearing full personal protective equipment uses a large microscope device during an operation

Jun 15, 2021 by Steve Ditto

Is Intuitive Surgical the Tesla of Healthcare?

Tesla hopes to dominate the car market using robots and artificial intelligence. Can Intuitive Surgical do the same in the operating room?

Steve Ditto

Recent Articles by Steve Ditto

Illumina Delivers a Beat and a Raise in Q2

Is It Too Late to Buy Idexx Laboratories?

Bets on Pets: Is Chewy or Idexx a Better Buy?

Better Buy: Vertex vs. CRISPR

Is Novavax a Buy?

Is Moderna a Buy?

3 Things About Regeneron That Smart Investors Know

3 Things About Vertex Pharmaceuticals That Smart Investors Know

3 Things About CRISPR Therapeutics That Smart Investors Know

Is Illumina a Buy?

3 Things About Fulgent Genetics That Smart Investors Know

3 Things About Invitae That Smart Investors Should Know

Where Will ARK Genomic Revolution ETF Be in 5 Years?

Is It Too Late to Buy Intellia Therapeutics?

Has Illumina Lost Its Shine?

Is GoodRx the Prescription for Your Portfolio?

What Does Life After COVID Look Like for Fulgent Genetics?

Is Amazon Becoming a Healthcare Company?

Can Invitae Be the Winner-Take-Most in Genetic Testing?

Is Intuitive Surgical the Tesla of Healthcare?

Premium Investing Services